aspirin has been researched along with Giant Cell Arteritis in 61 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Giant Cell Arteritis: A systemic autoimmune disorder that typically affects medium and large ARTERIES, usually leading to occlusive granulomatous vasculitis with transmural infiltrate containing multinucleated GIANT CELLS. The TEMPORAL ARTERY is commonly involved. This disorder appears primarily in people over the age of 50. Symptoms include FEVER; FATIGUE; HEADACHE; visual impairment; pain in the jaw and tongue; and aggravation of pain by cold temperatures. (From Adams et al., Principles of Neurology, 6th ed)
Excerpt | Relevance | Reference |
---|---|---|
"To assess the safety and effectiveness of low-dose aspirin, as an adjunctive, in the treatment of giant cell arteritis (GCA)." | 8.90 | Aspirin as adjunctive treatment for giant cell arteritis. ( Burdon, MA; Denniston, AK; Mollan, SP; Sharrack, N, 2014) |
"To assess the safety and effectiveness of low-dose aspirin, as an adjunctive, in the treatment of giant cell arteritis (GCA)." | 4.90 | Aspirin as adjunctive treatment for giant cell arteritis. ( Burdon, MA; Denniston, AK; Mollan, SP; Sharrack, N, 2014) |
" Low-dose aspirin as adjuvant therapy should be considered in patients with giant cell arteritis." | 4.82 | [Temporal arteritis and cerebrovascular complications]. ( Kerty, E; Øverlie, H, 2005) |
" Bleeding complications occurred in 2 patients receiving aspirin, 1 patient receiving warfarin, and 5 patients who did not receive anticoagulant or antiplatelet therapy." | 3.73 | Antiplatelet and anticoagulant therapy in patients with giant cell arteritis. ( Galor, A; Hoffman, GS; Lee, MS; Smith, SD, 2006) |
"Giant cell arteritis is a chronic vasculitis affecting large and medium-sized arteries, most commonly the temporal and other cranial arteries." | 2.48 | Giant cell arteritis: a review of classification, pathophysiology, geoepidemiology and treatment. ( Borchers, AT; Gershwin, ME, 2012) |
"Although giant cell or temporal arteritis represents 5-10% of ischaemic optic neuropathies and is the most common arteritis in people over 60 years old." | 2.46 | [Temporal arteritis: treatment controversies]. ( Balsalobre Aznar, J; Porta-Etessam, J, 2010) |
"Prednisolone was initiated with clinical and analytical improvement." | 1.56 | Boundaries of a systemic disease: a protean presentation of giant cell arteritis. ( Brotas, V; Camara, L; Mesquita, A; Patrício, C, 2020) |
"Giant cell arteritis is a common cause of headache in patients aged more than 50 years." | 1.40 | A stroke of bad luck. ( Joshi, Y; Nagasayi, S; White, S, 2014) |
"Giant cell arteritis (GCA) or temporal arteritis (TA) with polymyalgia rheumatica (PMR) is among the most common reasons for long-term steroid prescription." | 1.36 | Concise guidance: diagnosis and management of giant cell arteritis. ( Dasgupta, B, 2010) |
" There has been no recurrence of pain after stepwise reduction over one year of the steroid dosage until its discontinuation." | 1.28 | [Giant-cell arteritis limited to the femoral arteries]. ( Baumann, G; Bogner, J; Haschka, C; Spengel, FA; Stautner-Brückmann, C, 1992) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (11.48) | 18.7374 |
1990's | 5 (8.20) | 18.2507 |
2000's | 28 (45.90) | 29.6817 |
2010's | 18 (29.51) | 24.3611 |
2020's | 3 (4.92) | 2.80 |
Authors | Studies |
---|---|
Hočevar, A | 1 |
Ješe, R | 1 |
Tomšič, M | 1 |
Rotar, Ž | 1 |
Mesquita, A | 1 |
Camara, L | 1 |
Patrício, C | 1 |
Brotas, V | 1 |
Stanescu, N | 1 |
Wood, K | 1 |
Greenberg, T | 1 |
Maklakovski, M | 1 |
Rubinov, A | 1 |
Dagan, A | 1 |
Sadrkhah, A | 1 |
Seebach, JD | 1 |
Muller, Y | 1 |
Kötter, I | 1 |
Stübiger, N | 1 |
Deuter, C | 1 |
Calle-Lopez, Y | 1 |
Fernandez-Ramirez, AF | 1 |
Franco-Dager, E | 1 |
Gomez-Lopera, JG | 1 |
Vanegas-Garcia, AL | 1 |
Nesher, G | 4 |
Poltorak, V | 1 |
Hindi, I | 1 |
Nesher, R | 2 |
Dror, Y | 1 |
Orbach, H | 1 |
Breuer, GS | 2 |
Samson, M | 1 |
Greigert, H | 1 |
Ghesquière, T | 1 |
Bonnotte, B | 1 |
Mollan, SP | 1 |
Sharrack, N | 1 |
Burdon, MA | 1 |
Denniston, AK | 1 |
Nagasayi, S | 1 |
White, S | 1 |
Joshi, Y | 1 |
Bnaya, A | 1 |
Sonenblick, M | 1 |
Assad, M | 1 |
Coffin-Pichonnet, S | 1 |
Billotte, C | 1 |
Denion, É | 1 |
Hoffman, GS | 2 |
Borg, FA | 2 |
Salter, VL | 1 |
Dasgupta, B | 5 |
Lorthioir, A | 1 |
Marie, I | 1 |
Tetart, F | 1 |
Bernet, J | 1 |
Lévesque, H | 2 |
Hall, JK | 1 |
Wipfler-Freissmuth, E | 1 |
Moosig, F | 1 |
Schirmer, M | 1 |
Schmidt, WA | 1 |
Berger, CT | 1 |
Wolbers, M | 1 |
Meyer, P | 1 |
Daikeler, T | 1 |
Hess, C | 1 |
Richard, S | 1 |
Anxionnat, R | 1 |
Delaunay, C | 1 |
Ducrocq, X | 1 |
Nancy, C | 1 |
Tsai, TY | 1 |
Massasso, D | 1 |
Sharma, P | 1 |
Crozier, J | 1 |
Balsalobre Aznar, J | 1 |
Porta-Etessam, J | 1 |
Borchers, AT | 1 |
Gershwin, ME | 1 |
Besada, E | 1 |
Nossent, JC | 1 |
Barraclough, K | 1 |
Mallen, CD | 1 |
Helliwell, T | 1 |
Hider, SL | 1 |
Mercado, JL | 1 |
Purvin, VA | 1 |
Kawasaki, A | 1 |
WuDunn, D | 1 |
Rothschild, BM | 1 |
Danesh-Meyer, H | 1 |
Weyand, CM | 2 |
Goronzy, JJ | 2 |
Garcia-Porrua, C | 3 |
Pego-Reigosa, R | 1 |
Armesto, V | 2 |
Gonzalez-Gay, MA | 3 |
Granel, B | 1 |
Serratrice, J | 1 |
Ene, N | 1 |
Morange, PE | 1 |
Disdier, P | 1 |
Weiller, PJ | 1 |
Berkun, Y | 2 |
Mates, M | 2 |
Baras, M | 2 |
Rubinow, A | 2 |
Sonnenblick, M | 2 |
Hellmann, DB | 1 |
Santamarina, R | 1 |
Benhamou, Y | 1 |
Espinoza, LR | 1 |
Øverlie, H | 1 |
Kerty, E | 1 |
Wouters, JM | 1 |
Spiera, RF | 1 |
Spiera, H | 1 |
Lee, MS | 1 |
Smith, SD | 1 |
Galor, A | 1 |
Sander, O | 1 |
Schneider, M | 1 |
Yazici, Y | 1 |
Andrade, J | 1 |
Al Ali, A | 1 |
Saw, J | 1 |
Wong, GC | 1 |
Mukhtyar, C | 1 |
Guillevin, L | 1 |
Cid, MC | 1 |
de Groot, K | 1 |
Gross, W | 1 |
Hauser, T | 1 |
Hellmich, B | 1 |
Jayne, D | 1 |
Kallenberg, CG | 1 |
Merkel, PA | 1 |
Raspe, H | 1 |
Salvarani, C | 1 |
Scott, DG | 1 |
Stegeman, C | 1 |
Watts, R | 1 |
Westman, K | 1 |
Witter, J | 1 |
Yazici, H | 1 |
Luqmani, R | 1 |
Calkins, E | 1 |
Nielsen, IL | 1 |
Rasmussen, S | 1 |
Hilden, T | 1 |
Lee, AG | 1 |
Caramaschi, P | 1 |
Biasi, D | 1 |
Carletto, A | 1 |
Zeminian, S | 1 |
Manzo, T | 1 |
Bambara, LM | 1 |
Brañas, F | 1 |
Sanges, G | 1 |
Sampaolo, S | 1 |
Di Iorio, G | 1 |
Kaiser, M | 1 |
Yang, H | 1 |
Younge, B | 1 |
Parkes, JD | 1 |
Stautner-Brückmann, C | 1 |
Haschka, C | 1 |
Baumann, G | 1 |
Bogner, J | 1 |
Spengel, FA | 1 |
Hart, FD | 1 |
Huskisson, EC | 1 |
Vojtìsek, O | 1 |
Kankovà, D | 1 |
Millikan, CH | 1 |
Das, AK | 1 |
Laskin, DM | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
The Role of Ultrasound Compared to Biopsy of Temporal Arteries in the Diagnosis and Treatment of Giant Cell Arteritis (GCA).[NCT00974883] | 880 participants (Actual) | Observational | 2010-06-30 | Completed | |||
Study of the Benefit of Early Treatment With an Endothelin Inhibitor (Bosentan) in Patients With Sudden Blindness Due to Giant Cell Arteritis: CECIBO[NCT03841734] | Phase 3 | 8 participants (Anticipated) | Interventional | 2019-03-31 | Not yet recruiting | ||
VCRC Imaging Protocol for Magnetic Resonance and Positron Emission Tomography in Large-vessel Vasculitis (Takayasu's Arteritis):Development as Clinical Trial Outcome Measures[NCT00744952] | 26 participants (Actual) | Observational | 2008-08-31 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
19 reviews available for aspirin and Giant Cell Arteritis
Article | Year |
---|---|
[Ocular involvement in rheumatoid arthritis, connective tissue diseases and vasculitis].
Topics: Acute Disease; Adrenal Cortex Hormones; Arthritis, Rheumatoid; Aspirin; Collagen Diseases; Cross-Sec | 2017 |
[Treatment of giant cell arteritis].
Topics: Abatacept; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Aspirin; Azat | 2019 |
Aspirin as adjunctive treatment for giant cell arteritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chemotherapy, Adjuvant; Giant Cell Arteritis; Huma | 2014 |
[Giant cell arteritis--old questions, current answers].
Topics: Aged; Anti-Inflammatory Agents; Aspirin; Biomarkers; Biopsy; Disease Management; Giant Cell Arteriti | 2014 |
Giant Cell Arteritis.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diagnosis, Differential; | 2016 |
Neuro-ophthalmic complications in giant cell arteritis.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Aspirin; Cytokines; Giant Cell Arteritis; Humans; | 2008 |
Giant-cell arteritis.
Topics: Aspirin; Blood Sedimentation; C-Reactive Protein; Fibrinogen; Fluorodeoxyglucose F18; Giant Cell Art | 2008 |
[Polymyalgia rheumatica and giant cell arteritis. New aspects in diagnosis and treatment].
Topics: Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diagnosis, Differe | 2008 |
[Temporal arteritis: treatment controversies].
Topics: Aspirin; Benzamides; Giant Cell Arteritis; Glucocorticoids; Humans; Imatinib Mesylate; Immunosuppres | 2010 |
Giant cell arteritis: a review of classification, pathophysiology, geoepidemiology and treatment.
Topics: Aorta; Aortic Aneurysm; Aspirin; Azathioprine; Dendritic Cells; Female; Giant Cell Arteritis; Humans | 2012 |
Ultrasonographic resolution of the vessel wall oedema with modest clinical improvement in a large-vessel vasculitis patient treated with tocilizumab.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Aspirin; Biopsy; | 2012 |
Giant cell arteritis: managing the ophthalmic medical emergency.
Topics: Adrenal Cortex Hormones; Anticoagulants; Aspirin; Emergency Medical Services; Giant Cell Arteritis; | 2003 |
Medium- and large-vessel vasculitis.
Topics: Adolescent; Adrenal Cortex Hormones; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Aspirin; Dru | 2003 |
Medium- and large-vessel vasculitis.
Topics: Adolescent; Adrenal Cortex Hormones; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Aspirin; Dru | 2003 |
Medium- and large-vessel vasculitis.
Topics: Adolescent; Adrenal Cortex Hormones; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Aspirin; Dru | 2003 |
Medium- and large-vessel vasculitis.
Topics: Adolescent; Adrenal Cortex Hormones; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Aspirin; Dru | 2003 |
Risk factors for cranial ischemic complications in giant cell arteritis.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain Ischemia; Female; G | 2004 |
Low-dose aspirin in the treatment of giant cell arteritis.
Topics: Aspirin; Blindness; Giant Cell Arteritis; Humans; Ischemia; Platelet Aggregation Inhibitors | 2004 |
[Temporal arteritis and cerebrovascular complications].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chemotherapy, Adjuvant; G | 2005 |
[Temporal arteritis].
Topics: Age Factors; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Catheter Ablation; Diagnosis, D | 2007 |
Vasculitis update, 2007.
Topics: Adrenal Cortex Hormones; Anticoagulants; Antirheumatic Agents; Aspirin; Cyclophosphamide; Giant Cell | 2007 |
[Polymyalgia rheumatica (comprehensive review)].
Topics: Age Factors; Aspirin; Blood Protein Electrophoresis; Blood Sedimentation; Diagnosis, Differential; G | 1973 |
42 other studies available for aspirin and Giant Cell Arteritis
Article | Year |
---|---|
Risk factors for severe cranial ischaemic complications in giant cell arteritis.
Topics: Age Factors; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain Ischem | 2020 |
Boundaries of a systemic disease: a protean presentation of giant cell arteritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cholestasis; Cough; Diagnosis, Differential; Drug | 2020 |
Hemi-central Retinal Artery Occlusion Associated with Giant Cell Arteritis.
Topics: Anti-Inflammatory Agents; Aspirin; Biomarkers; Biopsy; Female; Fluorescein Angiography; Fundus Oculi | 2021 |
[Large vessel vasculitis : pathogenesis, diagnostic and medical management].
Topics: Aspirin; Biological Products; Giant Cell Arteritis; Glucocorticoids; Humans; Inflammation; Takayasu | 2017 |
[«Man-in-the-barrel» syndrome: atypical manifestation of giant cell arteritis].
Topics: Aged; Aorta; Aspirin; Brachial Plexus Neuropathies; Craniofacial Fibrous Dysplasia; Electromyography | 2018 |
Survival of patient with giant cell arteritis: Impact of vision loss and treatment with aspirin.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Giant Cell Arteri | 2019 |
My father has been diagnosed with giant cell arteritis. What is this, and is it a serious?
Topics: Adrenal Cortex Hormones; Age Distribution; Aspirin; Female; Giant Cell Arteritis; Humans; Male; Sex | 2013 |
A stroke of bad luck.
Topics: Aspirin; Female; Giant Cell Arteritis; Headache; Humans; Middle Aged; Steroids; Stroke | 2014 |
[Acute unilateral arteritic anterior ischemic optic neuropathy becoming bilateral despite corticosteroid therapy].
Topics: Acute Disease; Aged; Alzheimer Disease; Anti-Inflammatory Agents; Anticoagulants; Aspirin; Disease P | 2016 |
[Mesenteric artery involvement in giant cell arteritis: two cases and literature review].
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Aorta, Abdominal; Aortitis; Arteritis; Aspirin; B | 2008 |
[Recommendations of the European League Against Rheumatism (EULAR) for the treatment of "large-vessel vasculitides"].
Topics: Antirheumatic Agents; Aspirin; Etanercept; Europe; Evidence-Based Medicine; Giant Cell Arteritis; Gl | 2009 |
Giant cell arteritis: not just a stroke in the eye.
Topics: Aspirin; Blindness; Drug Therapy, Combination; Early Diagnosis; Giant Cell Arteritis; Glucocorticoid | 2008 |
High incidence of severe ischaemic complications in patients with giant cell arteritis irrespective of platelet count and size, and platelet inhibition.
Topics: Aged; Aged, 80 and over; Aspirin; Blood Platelets; Brain Ischemia; Cell Size; Female; Giant Cell Art | 2009 |
Giant cell arteritis revealed by vertebrobasilar insufficiency.
Topics: Aged; Anti-Inflammatory Agents; Aspirin; Biopsy; Brain Stem Infarctions; Disease Progression; Fatal | 2009 |
Taking PET for a walk - an unusual cause of bilateral leg claudication.
Topics: Alendronate; Anti-Inflammatory Agents; Aspirin; Drug Therapy, Combination; Female; Giant Cell Arteri | 2010 |
Concise guidance: diagnosis and management of giant cell arteritis.
Topics: Aspirin; Blindness; Diagnosis, Differential; Diagnostic Imaging; Early Diagnosis; Giant Cell Arterit | 2010 |
Diagnosis and management of giant cell arteritis.
Topics: Administration, Oral; Anti-Inflammatory Agents; Aspirin; Biopsy; Giant Cell Arteritis; Glucocorticoi | 2012 |
Bilateral sequential nonarteritic anterior ischemic optic neuropathy: a comparison of visual outcomes in fellow eyes using quantitative analysis of goldmann visual fields.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Aspirin; Carbonic Anhydrase Inhibitors; | 2012 |
Benefit or risk of aspirin treatment of giant cell arteritis: comment on the article by Weyand et al.
Topics: Aspirin; Giant Cell Arteritis; Humans | 2002 |
Neovascularization around the optic nerve in giant cell arteritis.
Topics: Aged; Aspirin; Giant Cell Arteritis; Humans; Magnetic Resonance Imaging; Male; Neovascularization, P | 2003 |
Juvenile temporal arteritis and activated protein C resistance.
Topics: Activated Protein C Resistance; Adult; Anti-Inflammatory Agents; Aspirin; Giant Cell Arteritis; Huma | 2004 |
Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Aspirin; Blindness; Drug Therapy, Combination; Fe | 2004 |
Magnetic resonance imaging in optic neuritis due to giant cell arteritis.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dru | 2005 |
[Aspirin and temporal arteritis].
Topics: Animals; Aspirin; Giant Cell Arteritis; Humans; Platelet Aggregation Inhibitors | 2005 |
Clinical trials in giant cell arteritis.
Topics: Aspirin; Brain Ischemia; Clinical Trials as Topic; Dose-Response Relationship, Drug; Giant Cell Arte | 2005 |
[Polymyalgia rheumatica and temporal arteritis].
Topics: Aspirin; Fibrinolytic Agents; Giant Cell Arteritis; Glucocorticoids; Humans; Interferon-gamma; Inter | 2005 |
Therapy for giant cell arteritis: can we do better?
Topics: Adrenal Cortex Hormones; Anticoagulants; Aspirin; Comorbidity; Dose-Response Relationship, Drug; Gia | 2006 |
Antiplatelet and anticoagulant therapy in patients with giant cell arteritis.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Brain Ischemia; Clopidogrel; Cohort Studies; Dose- | 2006 |
Acute stent thrombosis in a patient with giant cell arteritis.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Angiography; Coronary Artery Di | 2008 |
EULAR recommendations for the management of large vessel vasculitis.
Topics: Aspirin; Drug Monitoring; Drug Therapy, Combination; Evidence-Based Medicine; Giant Cell Arteritis; | 2009 |
Rheumatic diseases in the elderly. Finding a way through the maze.
Topics: Aged; Arthritis, Rheumatoid; Aspirin; Chondrocalcinosis; Giant Cell Arteritis; Gold; Humans; Medical | 1982 |
Acetylsalicylic acid and renal function.
Topics: Aged; Aspirin; Bone Diseases; Creatinine; Female; Giant Cell Arteritis; Glomerular Filtration Rate; | 1980 |
Bilateral nonarteritic anterior ischemic optic neuropathy.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Giant Cell Arteritis; Humans; Optic Neuropathy, Is | 1997 |
Large artery giant cell arteritis: a diagnosis to remember.
Topics: Aged; Aged, 80 and over; Angiography; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroi | 1997 |
Carotid occlusion mimicking giant cell arteritis.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Blindness; Captopril; Carotid Artery Diseas | 1998 |
Craniofacial pain followed by scalp necrosis and stroke. An unusual presentation of the primary antiphospholipid syndrome.
Topics: Aged; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Autoimmune D | 1999 |
Therapeutic effects of acetylsalicylic acid in giant cell arteritis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dexamethasone; Drug Synergism; Giant Cell | 2002 |
Diseases of the central nervous system. Relief of pain: headache, facial neuralgia, migraine, and phantom limb.
Topics: Analgesics; Aspirin; Carbamazepine; Ergotamines; Facial Neuralgia; Giant Cell Arteritis; Headache; H | 1975 |
[Giant-cell arteritis limited to the femoral arteries].
Topics: Aspirin; Exercise Therapy; Female; Femoral Artery; Follow-Up Studies; Giant Cell Arteritis; Humans; | 1992 |
Pain patterns in the rheumatic disorders.
Topics: Anxiety; Arthritis; Arthritis, Rheumatoid; Aspirin; Chronic Disease; Depression; Giant Cell Arteriti | 1972 |
Address of the president-elect: the indication for various methods of treatment of occlusive cerebrovascular disease.
Topics: Anticoagulants; Aspirin; Blood Pressure; Cardiac Output; Carotid Arteries; Cerebral Angiography; Cer | 1973 |
Temporal arteritis of the facial artery.
Topics: Adrenal Cortex Hormones; Aged; Aspirin; Codeine; Diagnosis, Differential; Giant Cell Arteritis; Huma | 1966 |